文献速递肺外科

欧洲胸外科医师学会并发症与死亡风险模型的外部验证

External validation of the European Society of Thoracic Surgeons morbidity and mortality risk models.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究在全国多中心2858例2016至2018年接受解剖性肺切除术的患者中,对Eurolung 1(心肺并发症)和Eurolung 2(30天死亡)模型进行外部验证。Eurolung 2校准良好且区分度可接受,AUC ROC为0.760;Eurolung 1校准欠佳且区分度较低,AUC ROC为0.653。结论认为30天死亡评分似可推广至其他解剖性肺切除患者,而术后心肺并发症评分似对新患者泛化性不足。

要点

  • Eurolung 2(30天死亡)外部验证校准良好,AUC ROC为0.760(95%CI 0.701-0.819)。
  • Eurolung 1(心肺并发症)校准欠佳,AUC ROC为0.653(95%CI 0.623-0.684)。
  • 作者认为30天死亡评分似可推广,心肺并发症评分泛化性似不足。

核心结论

  • 30天死亡评分(Eurolung 2)似可推广至其他解剖性肺切除患者。
  • 术后心肺并发症评分(Eurolung 1)似对新患者泛化性不足。

研究设计与样本

  • 外部验证研究,基于全国多中心数据库2858例2016至2018年接受解剖性肺切除术的患者。
  • 通过校准图、Brier分数和Hosmer-Lemeshow检验评估校准,通过受试者工作特征曲线下面积(AUC ROC)评估区分度。

主要发现

  • Eurolung 1校准图显示重叠欠佳(斜率=0.921),Hosmer-Lemeshow检验P=0.353,Brier分数=0.104。
  • Eurolung 1的AUC ROC为0.653(95%CI 0.623-0.684)。
  • Eurolung 2校准良好(斜率=1.038),Hosmer-Lemeshow检验P=0.234,Brier分数=0.020。
  • Eurolung 2的AUC ROC为0.760(95%CI 0.701-0.819)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There is a wide variety of predictive models of postoperative risk, although some of them are specific to thoracic surgery, none of them is widely used. The European Society for Thoracic Surgery has recently updated its models of cardiopulmonary morbidity (Eurolung 1) and 30-day mortality (Eurolung 2) after anatomic lung resection. The aim of our work is to carry out the external validation of both models in a multicentre national database. METHODS: External validation of Eurolung 1 and Eurolung 2 was evaluated through calibration (calibration plot, Brier score and Hosmer-Lemeshow test) and discrimination [area under receiver operating characteristic curves (AUC ROC)], on a national multicentre database of 2858 patients undergoing anatomic lung resection between 2016 and 2018. RESULTS: For Eurolung 1, calibration plot showed suboptimal overlapping (slope = 0.921) and a Hosmer-Lemeshow test and Brier score of P = 0.353 and 0.104, respectively. In terms of discrimination, AUC ROC for Eurolung 1 was 0.653 (95% confidence interval, 0.623-0.684). In contrast, Eurolung 2 showed a good calibration (slope = 1.038) and a Hosmer-Lemeshow test and Brier score of P = 0.234 and 0.020, respectively. AUC ROC for Eurolung 2 was 0.760 (95% confidence interval, 0.701-0.819). CONCLUSIONS: Thirty-day mortality score (Eurolung 2) seems to be transportable to other anatomic lung-resected patients. On the other hand, postoperative cardiopulmonary morbidity score (Eurolung 1) seems not to have sufficient generalizability for new patients.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gómez de Antonio D, Crowley Carrasco S, Romero Román A, et al. External validation of the European Society of Thoracic Surgeons morbidity and mortality risk models. Eur J Cardiothorac Surg. 2022. PMID: 35301527. doi:10.1093/ejcts/ezac170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。